Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 92, Issue 5, Pages 467-476Publisher
SPRINGER
DOI: 10.1007/s00223-013-9702-1
Keywords
Osteoporosis; Genetics; Muscle; Fracture; Polymorphism
Categories
Funding
- World Anti-Doping Agency
- Novo Nordisk Foundation
- Danish Ministry of Culture
- Clinical Institute at University of Southern Denmark
- Villum Kann Rasmussen Foundation
- Jacob Madsen and Spouse Olga Madsens Foundation
- Family Hede Nielsen Foundation
- Danish Osteoporosis Foundation
- Brothers Hartmann Foundation
- A.P. Moller Foundation
- Novo Nordisk
Ask authors/readers for more resources
The interaction between muscle and bone is complex. The aim of this study was to investigate if variations in the muscle genes myostatin (MSTN), its receptor (ACVR2B), myogenin (MYOG), and myoD1 (MYOD1) were associated with fracture risk, bone mineral density (BMD), bone mineral content (BMC), and lean body mass. We analyzed two independent cohorts: the Danish Osteoporosis Prevention Study (DOPS), comprising 2,016 perimenopausal women treated with hormone therapy or not and followed for 10 years, and the Odense Androgen Study (OAS), a cross-sectional, population-based study on 783 men aged 20-29 years. Nine tag SNPs in the four genes were investigated. In the DOPS, individuals homozygous for the variant allele of the MSTN SNP rs7570532 had an increased risk of any osteoporotic fracture, with an HR of 1.82 (95 % CI 1.15-2.90, p = 0.01), and of nonvertebral osteoporotic fracture, with an HR of 2.02 (95 % CI 1.20-3.41, p = 0.01). The same allele was associated with increased bone loss (BMC) at the total hip of 4.1 versus 0.5 % in individuals either heterozygous or homozygous for the common allele (p = 0.006), a reduced 10-year growth in bone area at the total hip of 0.4 versus 2.2 and 2.3 % in individuals heterozygous or homozygous for the common allele, respectively (p = 0.01), and a nonsignificantly increased 10-year loss of total-hip BMD of 4.4 versus 2.7 and 2.9 % in individuals heterozygous or homozygous for the common allele, respectively (p = 0.08). This study is the first to demonstrate an association between a variant in MSTN and fracture risk and bone loss. Further studies are needed to confirm the findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available